Resolution 1896 of 2023, contains regulations on non-promotional information, promotion, marketing, and advertising of medicinal products.
It sets out the conditions for the promotion of over the counter (OTC) medicines, as well as the restrictions on the advertising of prescription medicines (-RX – which may only be directed to professionals authorized by law to prescribe them).
Advertising and promotion of OTC medicines must be notified to INVIMA prior to launch and will be subject to market surveillance (prior authorization is no longer required). Advertising of RX medicines must also be notified, as well as non-promotional information of pharmaceutical products.
Influencers will also be responsible for violations of the sanitary regime, as well as the MA holder. Criteria for online marketing of pharmaceutical products are also provided.
Original source in Spanish.
